Scientific Publications Related to Calprotectin
Related Guidelines
|
National Institute for Health and Care Excellence. NICE Diagnostics
guidance DG11. Faecal calprotectin diagnostic tests for inflammatory
diseases of the bowel. Published: 2013 Oct 02.
|
|
National Institute for Health and Care Excellence. NICE Clinical guideline
CG61. Irritable bowel syndrome in adults: diagnosis and management.
Published: 2008 Feb 23. Updated: 2017 Apr 04.
|
|
Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese
E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F,
Eliakim R, Ellul P, González-Lama Y, Gordon H, Halligan S, Katsanos K,
Kopylov U, Kotze PG, Krustinš E, Laghi A, Limdi JK, Rieder F, Rimola J,
Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J; European Crohn’s
and Colitis Organisation [ECCO] and the European Society of Gastrointestinal
and Abdominal Radiology [ESGAR]. ECCO-ESGAR Guideline for Diagnostic
Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD,
detection of complications. J Crohns Colitis. 2019 Feb
1;13(2):144-164.
|
|
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer
MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S,
Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J,
Terry H; IBD guidelines eDelphi consensus group, Gaya DR, Iqbal TH, Taylor
SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of
Gastroenterology consensus guidelines on the management of inflammatory
bowel disease in adults. Gut. 2019 Dec;68(Suppl 3):s1-s106. Erratum in: Gut.
2021 Apr;70(4):1.
|
|
Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM,
Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W,
Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu
MT, Dignass A; International Organization for the Study of IBD. STRIDE-II:
An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease
(STRIDE) Initiative of the International Organization for the Study of IBD
(IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in
IBD. Gastroenterology. 2021 Apr;160(5):1570-1583.
|
Key Literature of Our NESCAUTO® Cp Auto Products
|
Inoue K, Aomatsu T, Yoden A, Okuhira T, Kaji E, Tamai H. Usefulness of a
novel and rapid assay system for fecal calprotectin in pediatric patients
with inflammatory bowel diseases. J Gastroenterol Hepatol.
2014;29(7):1406-12.
|
|
Okuyama Y, Doi Y, Matsuyama N, Uchino M, Yamamoto T. A novel sol particle
immunoassay for fecal calprotectin in inflammatory bowel disease patients.
Clin Chim Acta. 2016 May 1;456:1-6.
|
|
Yamamoto T, Shimoyama T, Umegae S, Matsumoto K. Serial monitoring of faecal
calprotectin for the assessment of endoscopic recurrence in asymptomatic
patients after ileocolonic resection for Crohn's disease: a long-term
prospective study. Therap Adv Gastroenterol. 2016 Sep;9(5):664-70.
|
|
Shimoyama T, Yamamoto T, Umegae S, Matsumoto K. Faecal biomarkers for
screening small bowel inflammation in patients with Crohn's disease: a
prospective study. Therap Adv Gastroenterol. 2017 Aug;10(8):577-587.
|
Related Pages
